Online Symposium, October 19th 2021
This virtual symposium with vet colleagues discussed comparative systemic therapies in canine vs human atopic dermatitis. This was a global event with speakers and panelists from America, Europe, Japan, and the Middle East.
Faculty
- Thierry OLIVRY, DV, PhD, Dip European & American College VD
- Pascal PRÉLAUD, DV, Dip European College VD
- Chie TAMAMOTO MOCHIZUKI, DVM, PhD, Dip Asian College CVD
- Claude FAVROT, DV, MS, Diplomate European College of VD, Zürich
- Lisa BECK, MD PhD
- Kenji KABASHIMA, MD PhD
- Martin STEINHOFF, MD PhD
- Peter SCHMID-GRENDELMEIER, ISAD
- Andreas WOLLENBERG, ISAD
- Amy PALLER, ISAD
- Roberto TAKAOKA, ISAD
- Alain TAÏEB, ISAD
Programme of the meeting
| 02:00 pm |
Introduction
Alain TAÏEB |
|
| PRESENTATIONS (1 h 30) | ||
| 10 mn |
CAD and HAD: same disease with different therapeutic approach
Pascal PRELAUD |
|
| 15 mn |
How dupilumab has changed the treatment paradigm for severe HAD
Lisa BECK |
|
| 15 mn |
Lokivetmab (anti-IL31): proactive and reactive use
Thierry OLIVRY and Chie TAMAMOTO MOCHIZUKI |
|
| 15 mn |
Anti IL31Rα therapy in HAD and prurigo nodularis
Kenji KABASHIMA |
|
| 10 mn |
Oclacitinib: fast, not furious
Pascal PRELAUD |
|
| 10 mn |
Glucocorticoids, ciclosporine, oclacitinib and anti-IL31: new paradigms of systemic treatment of AD
Thierry OLIVRY |
|
| 15 mn |
Pruritus biology and the new generation of JAK inhibitors vs anti TH2 cytokine biologics
Martin STEINHOFF |
|
|
GENERAL DISCUSSION (1 h)
Moderators: AW AP PSG TO PP JR RT CF |
||
|
Conclusions
Thierry OLIVRY & Alain TAÏEB |
Videos
Meeting’s recording
➜ Please sign-in or register to watch (free).